Finnish pharma market fell 1% in 2010
This article was originally published in Scrip
The value of Finnish pharmaceutical market fell by 1% to €1.96 billion at wholesale prices last year after it remained unchanged at €1.98 billion in 2008 and 2009, according to Pharma Industry Finland (PIF). Sales of prescription medicines were €1.73 billion, and those of OTC products rose by 26% to €225 million.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.